ArticleHealth science reports2026
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Methods: A systematic literature search was conducted from January to April 2025 using Web of Science, PubMed, Science Direct, and Google Scholar. Approximately 115 papers were initially screened, with 86 selected for comprehensive review. The data covered publications from 2011 to 2025, focusing on keywords related to Results: Phytochemical studies revealed diverse bioactive constituents, including flavonoids (quercetin, morin), phenolic acids (gallic acid, protocatechuic acid), triterpenes (oleanolic acid, myricadiol), and sterols (β-sitosterol). Pharmacological investigations demonstrated antidiabetic, antioxidant, anticancer, antimicrobial, anti-inflammatory, anti-ulcer, antihistaminic, and analgesic effects. Extracts significantly reduced hyperglycemia, improved lipid profiles, scavenged free radicals, and inhibited tumor growth in experimental models. Toxicology assessments indicated a high safety margin with no observed toxicity or mortality at doses above 3000 mg/kg in animals. Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.